Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury

American Journal of Pathology

Volumn 149, Issue 3, 1996, Pages 845-852

  Bardales, Ricardo H ^a,b   Xie, Su Su ^a,b   Schaefer, Robert F ^a,b   Hsu, Su Ming ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; CYCLOPHOSPHAMIDE; METHOTREXATE; STEROID;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL TYPE 2; LUNG BURN; LUNG INJURY; LUNG SQUAMOUS CELL CARCINOMA; MALE; NONHODGKIN LYMPHOMA; PNEUMONIA; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL DIVISION; CHRONIC DISEASE; FEMALE; HUMANS; HYPERPLASIA; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONIA; PROLIFERATING CELL NUCLEAR ANTIGEN; PULMONARY ALVEOLI; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0029770134     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Katzenstein ALA, Askin FB (eds): Acute lung injury patterns. Surgical Pathology of Non-Neoplastic Lung Disease, ed 2. Philadelphia, WB Saunders, 1990, pp 9-57
2. Stanley MW, Henry-Stanley MJ, Gajl-Peczalska K, Bitterman PB: Hyperplasia of type II pneumocytes in acute lung injury: cytologic findings of sequential bronchoalveolar lavage. Am J Clin Pathol 1992, 97:669-677
3. Adamson I, Bowden C: The type 2 cell as progenitor of alveolar epithelial regeneration: a cytodynamic study in mice after exposure to oxygen. Lab Invest 1974, 30: 35-42
4. 2. Am J Pathol 1973, 70:175-198
5. 2. Exp Mol Pathol 1975, 22:142-150
6. Brody JS, Burki R, Kaplan N: Deoxyribonucleic acid synthesis in lung cells during compensatory lung growth after pneumonectomy. Am Rev Respir Dis 1978, 117:307-316
7. Smith LJ: The effect of type II cell mitosis on the surfactant of injured mouse lungs. J Lab Clin Med 1983, 102:434-443
8. Ulich TR, Yi ES, Longmuir K, Yin S, Biltz R, Morris CF, Housley RM, Pierce G: Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 1994, 94:1298-1306
9. Majno G, Joris I: Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995, 146:3-15
10. Wyllie AH: Cell death: a new classification separating apoptosis from necrosis. Cell Death in Biology and Pathology. Edited by ID Bowen, RA Lockshin. London, Chapman and Hall, 1981, pp 9-34
11. Stewart BW: Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 1994, 86:1286-1296
12. Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984, 142:67-77
13. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501
14. Wijsman JH, Jonker RR, Keijzer R, Van de Velde CJH, Cornelisse CJ, Van Dierendonck JH: A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993, 41:7-12
15. Ansari R, Coates PJ, Greenstein BD, Hall PA: In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993, 170:1-8
16. Fukasawa Y, Ishikura H, Takada A, Yokoyama S, Imamura M, Yoshiki T, Sato H: Massive apoptosis in infantile myofibromatosis: a putative mechanism of tumor regression. Am J Pathol 1994, 144:480-485
17. Bardales RH, Hailey LS, Xie SS, Schaefer RF, Hsu SM: In situ apoptosis assay for early detection of acute myocardial infarction. Am J Pathol 1996, 149:821-829
18. Kawano H, Okada R, Kawano Y, Sueyoshi N, Shirai T: Apoptosis in acute and chronic myocarditis. Jpn Heart J 1994, 35:745-750
19. Kasagi N Gomyo Y, Shirai H, Tsujitani S, Ito H: Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Jpn J Cancer Res 1994, 85:939-945
20. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Jie T, Ito K: DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 1995, 146:1325-1331
21. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995, 146:56-66
22. Kressel M, Groscurth P: Distinction of apoptotic and necrotic cell death by in situ labeling of fragmented DNA. Cell Tissue Res 1994, 278:549-556
23. James TN, Terasaki F, Pavlovich, Vikhert AM: Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J Lab Clin Med 1993, 122:309-323
24. James TN: Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994, 90:556-573
25. Polunovsky VA, Chen B, Henke C, Snover D, Wendt C, Ingbar DH, Bitterman PB: Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 1993, 92:388-397
26. Nash JR, McLaughlin PJ, Butcher D, Corrin B: Expression of tumor necrosis factor-α in cryptogenic fibrosing alveolitis. Histopathology 1993, 22:343-347
27. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison of ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 1981, 29:577-580
28. Pulford KAF, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, Mason DY: KP1: A new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections J Clin Pathol 1989, 42:414-421
29. Wang NS: Anatomy. Pulmonary Pathology, Edited by DH Dail, SP Hammar. New York, Springer-Verlag, 1994, pp 30-31
30. Bardales RH, Morrow M, Moody MJ, Xie SS, Hsu SM: In situ DNA fragmentation assay to detect apoptosis in paraffin-embedded tissue sections: technical considerations. Mod Pathol 1995, 8:162a
31. Lwebuga-Mukasa JS: Matrix-driven pneumocyte differentiation. Am Rev Respir Dis 1991, 144:452-457
32. Panos RJ, Rubin JS, Aaronson SA, Mason RJ: Keratinocyte growth factor and hepatocyte growth factor/ scatter factor are heparin binding growth factors for alveolar type II cells in conditioned medium. J Clin Invest 1993, 92:969-977
33. Raaberg L, Nex E, Buckley S, Luo W, Snead ML, Warburton D: Epidermal growth factor transcription, translation, and signal transduction by rat type II pneumocytes in culture. Am J Respir Cell Mol Biol 1992, 6:44-49
34. Chess P, Ryan RM, Finkelstein JN: Tyrosine kinase activity is necessary for growth factor-stimulated rabbit type II pneumocyte proliferation. Pediatr Res 1994, 36:481-486
35. 2-exposed rat lung. Am J Physiol 1995, 268: L455-L464
36. Thurlbeck WM, Miller RR, Muller NL, Rosenow EC: Abnormal structure and function of the lung. Diffuse Diseases of the Lung: A Team Approach. Edited by WM Thurlbeck. Philadelphia, BC Decker, 1991, pp 18-29
37. Ryan RM, Mineo-Kuhn MM, Kramer CM, Finkelstein JN: Growth factors alter neonatal type II alveolar epithelial cell proliferation. Am J Physiol 1994, 266:L17-L22
38. Nash JRG, McLaughlin PJ, Hoyle C, Roberts D: Immunolocalization of tumor necrosis factor-α in lung tissue from patients dying with adult respiratory distress syndrome. Histopathology 1991, 19:395-402
39. Stahlman MT, Orth DN, Gray ME: Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate. Lab Invest 1989, 60:539-547
40. Guinee DG, Woodward ML, Walls J: p53 and WAF1 expression in diffuse alveolar damage: an example of p53 upregulation in non-neoplastic pulmonary disease. Am J Clin Pathol 1995, 104:331